U.S., June 25 -- ClinicalTrials.gov registry received information related to the study (NCT07666620) titled 'Efficacy of Clobetasol Vs Intralesional Triamcinolone in Lichen Planus Treatment' on June 12.
Brief Summary: The purpose of this study is to compare the efficacy and safety of two standard corticosteroid treatments for hypertrophic lichen planus (HLP), a chronic inflammatory skin condition that causes thick, intensely itchy plaques.
Patients participating in the study will be randomly assigned to one of two treatment groups:
* Group A will apply a superpotent topical steroid cream (Clobetasol propionate 0.05%) to their lesions twice daily for 12 weeks.
* Group B will receive intralesional injections of a steroid medication (Triam...